Association of the Brain-derived Neurotrophic Factor Gene and Clinical Features of Bipolar Disorder in Korea.
10.9758/cpn.2012.10.3.163
- Author:
Hye Ji MIN
1
;
Hyun Sang CHO
;
Se Joo KIM
;
Jeong Ho SEOK
;
Eun LEE
;
Duk In JON
Author Information
1. Department of Psychiatry, Hallym University College of Medicine, Anyang, Korea. cogni@naver.com
- Publication Type:Original Article
- Keywords:
Bipolar disorder;
Brain-derived neurotrophic factor;
Polymorphism;
Age of onset
- MeSH:
Age of Onset;
Bipolar Disorder;
Brain-Derived Neurotrophic Factor;
Cell Death;
Cell Survival;
Gene Frequency;
Genetic Predisposition to Disease;
Genetic Variation;
Genotype;
Humans;
Korea
- From:Clinical Psychopharmacology and Neuroscience
2012;10(3):163-167
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Brain-derived neurotrophic factor (BDNF) plays an important role in cell survival, differentiation, and cell death as well as in neural plasticity. Recent studies have suggested that BDNF is involved in the pathogenesis of bipolar disorder. The aim of this study was to investigate the association of the genetic variations of the BDNF gene with bipolar disorder in Korea. We also studied the possible association of these genetic variants with clinical features. METHODS: The allelic and genotypic distributions of Val66Met polymorphism of the BDNF gene were analyzed using a polymerase chain reaction-based method in 184 bipolar patients and 214 controls. Analysis was performed to investigate an association of the Val66Met polymorphism of the BDNF gene and the clinical features in bipolar patients. RESULTS: No significant difference was found between bipolar patients and controls in the genotype and allele frequencies for the investigated BDNF polymorphism. However, the age of onset of bipolar disorder among the Val/Val (25.57), Val/Met (30.42) and Met/Met (32.45) genotype groups were significantly different (p=0.037). CONCLUSION: This study suggests that Val66Met polymorphisms are unlikely to contribution to the genetic predisposition to bipolar disorder as a whole. But Val66Met polymorphism may be associated with age of onset of the disorder, further studies designed to investigate the relationship in a larger population may be warranted.
